Literature DB >> 23836246

Dyssegmental dysplasia, Silverman-Handmaker type: prenatal ultrasound findings and molecular analysis.

Noor Niyar N Ladhani1, David Chitayat, Marjan M Nezarati, Mittaz Crettol Laureane, Sarah Keating, Rachel J Silver, Sheila Unger, Lea Velsher, Wilma Sirkin, Ants Toi, Phyllis Glanc.   

Abstract

OBJECTIVES: The objective of this study is to describe the prenatal sonographic features and the results of DNA analysis on three fetuses with dyssegmental dysplasia, Silverman-Handmaker type (DD-SH).
METHODS: A retrospective review of three fetuses with confirmed DD-SH was conducted. The fetal ultrasound findings, the radiological characteristics, and the results of the mutation analysis of the heparan sulphate perlecan gene 2 (HSPG2) were reviewed.
RESULTS: There were three cases in two families with DD-SH diagnosed prenatally. The main prenatal ultrasound and the radiological features of DD-SH were severe limb shortening and vertebral segmentation and fusion defects (anisospondyly). The DNA analysis of the HSPG2 gene showed that the two affected fetuses in a nonconsanguineous family had a compound heterozygote for the c.646G > T transversion in exon 7 and a c.5788C > T transition in exon 46. The fetus born to the consanguineous couple had a homozygous mutation c.1356-27_1507 + 59del.
CONCLUSION: DD-SH can be diagnosed prenatally using fetal ultrasound as early as 13 weeks. Xrays and DNA analysis of the HSPG2 gene are important for the confirmation of the diagnosis and for the preimplantation and prenatal diagnosis in pregnancies at risk.
© 2013 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 23836246     DOI: 10.1002/pd.4193

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  2 in total

1.  Dyssegmental dysplasia, Silverman-Handmaker type: A challenging antenatal diagnosis in a dizygotic twin pregnancy.

Authors:  Shuaa Basalom; Yannis Trakadis; Roberta Shear; Michel E Azouz; Isabelle De Bie
Journal:  Mol Genet Genomic Med       Date:  2018-03-11       Impact factor: 2.183

Review 2.  Modular Proteoglycan Perlecan/HSPG2: Mutations, Phenotypes, and Functions.

Authors:  Jerahme R Martinez; Akash Dhawan; Mary C Farach-Carson
Journal:  Genes (Basel)       Date:  2018-11-16       Impact factor: 4.096

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.